In a pivotal step towards elevating dermatological care in the region, La Roche-Posay, a global leader in skincare, has signed a Memorandum of Understanding with King Faisal Specialist Hospital Foundation - Wareef Charity.
The partnership falls under the umbrella of La Roche-Posay’s internationally renowned “Fight with Care” program, which has a decade-long record of furthering cancer supportive care.
In line with L’Oréal Dermatological Beauty’s commitment to the progressive development and robust support of the skincare and haircare sectors, this initiative sets a precedent in enriching patient experiences, and enabling them to access invaluable information related to skin and hair care preservation across various stages of their life.
With God’s grace and success, we have signed a partnership agreement with the L’Oréal company to provide the company’s products to oncology and cancer patients to mitigate the effects of their treatments and to help them make their daily lives better.
Anwar Alsaqabi, CEO at Wareef Charity
The partnership is designed to strengthen and expand the support for patients undergoing chemotherapy at the King Faisal Specialist Hospital, offering them comprehensive training on the beneficial impact of dermo-cosmetics in alleviating treatment side effects. Throughout 2023, La Roche-Posay will provide specialized training to between 1,000-1,300 patients and donate thousands of units of its clinically proven skincare products, including Lipikar Baume AP+M and Cicaplast Baume B5.
Commenting on this partnership, Mohamed El Araby, general manager L’Oreal Dermatological beauty division, Middle East, said: “This marks an important stride in our overarching commitment to enhance the skincare sector in the region. This forward-thinking partnership is an extension of our commitment to provide world class training, support and products to dermatologists and patients. A first-of-its-kind in the region under our ‘Fight with Care’ program, will see us combining forces to empower and educate patients about the transformative role of dermo-cosmetics in their well-being journey.”
Remi Naser, brand director at La Roche-Posay, said: “We are thrilled to be joining forces with King Faisal Hospital Foundation - Wareef Charity under our longstanding ‘Fight with Care’ program. Eighty percent of cancer patients experience skin side effects, often leading to treatment interruptions. As such, we wanted to play a role in mitigating these effects by leveraging our decade-long expertise in skincare and oncology, to educate patients on the transformative role of dermo-cosmetics in their wellbeing journey. As part of this collaboration, La Roche-Posay will be supporting over 1,000 patients with dedicated skincare solutions as well as equip healthcare professionals with extensive training sessions. As we embark on this journey with King Faisal Hospital Foundation Wareef Charity, we look forward to harnessing the power of collaboration to improve patients’ lives during chemotherapy, to further allow them to navigate their treatment with enhanced comfort and confidence.”
Anwar Alsaqabi, CEO at Wareef Charity said: “With God’s grace and success, we have signed a partnership agreement with the L’Oréal company to provide the company’s products to oncology and cancer patients to mitigate the effects of their treatments and to help them make their daily lives better. The provision of L’Oréal products to the patients of King Faisal Specialist Hospital and Research Center, which is one of the largest and most reliable medical edifices in the Middle East, is highly appreciated. We express our deepest thanks for this community contribution, which indicates a close and great cooperation. And we are all confident in its success and sustainability,
God willing.”
